11:15 AM EDT, 07/29/2025 (MT Newswires) -- Thiogenesis Therapeutics ( TTIPF ) on Tuesday said it upsized a non-brokered private placement to raise about $4 million, up from its initial $1.5-million target.

The company said the offer size is being raised to an apparent 5.3-million shares (the company didn't specify millions in its release) from two-million shares at a price of $0.75 each. It said the upsized placement is fully subscribed.

Proceeds from the offering will be used for its Mitochondrial Encephalopathy Lactic Acidosis and Stroke (MELAS) clinical trial expenses, the creation and purchase of additional TTI-0102 for future clinical trials and general working capital.

The company's shares were last seen up $0.01 to $0.80 on the TSX Venture Exchange.

Price: 0.80, Change: +0.01, Percent Change: +1.27